Cloud-clone
SKU(재고 관리 코드):PAF422Hu01
Polyclonal Antibody to Fibulin 3 (FBLN3)
Polyclonal Antibody to Fibulin 3 (FBLN3)
Western blotting: 0.5-2µg/mL;
;Immunohistochemistry: 5-20µg/mL;
;Immunocytochemistry: 5-20µg/mL;
;Optimal working dilutions must be determined by end user.
Product No.
PAF422Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPF422Hu01-Recombinant Fibulin 3 (FBLN3)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
Mus musculus (Mouse), Rattus norvegicus (Rat)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against FBLN3. It has been selected for its ability to recognize FBLN3 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| 1 | Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma PubMed: PMC3761217 |
| Anticancer Res. | YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis. Pubmed: 24324091 |
| Oncology Reports | Role of fibulin-3 in lung cancer: In vivo and in vitro analyses Spandidos-publications: Source |
| Current Pulmonology Reports | Discovery of new biomarkers for malignant mesothelioma Springer:Source |
| United States Patent Application 20140378336 | DIAGNOSIS OF CELL PROLIFERATIVE DISEASES Freepatentsonline:Source |
| Thorax. | Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma Pubmed:Pmc4174124 |
| Egyptian Journal of Chest Diseases and Tuberculosis | Value of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions Pubmed:23050525 |
| Radiol Oncol | Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma PubMed: 26401134 |
| British Journal of Cancer | Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis PubMed: 26263483 |
| J Thorac Oncol. | Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. Pubmed:26903362 |
| BMJ Open | Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study pubmed:27884852 |
| 25 | HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients pubmed:26733616 |
| BMJ Journals | Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational … e013324.abstract |
| Anticancer Res. | Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma. pubmed:28314308 |
| Dis Markers. | A Novel Panel of Serum Biomarkers for MPM Diagnosis. pubmed:28348450 |
| The Knee | Association of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: A cross-sectional study pubmed:29195846 |
| Disease markers | Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population pubmed:29200597 |
| Molecular Medicine Reports | Placental protein 14 as a potential biomarker for diagnosis of preterm premature rupture of membranes Pubmed:29749501 |
| Oncotarget | The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion Pubmed:30046386 |
| Advances in Clinical and Experimental Medicine | Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with … 68362.pdf |
| PLoS One | Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals Pubmed: 30946771 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPF422Hu02 | Recombinant Fibulin 3 (FBLN3) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF422Hu01 | Recombinant Fibulin 3 (FBLN3) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF422Hu01 | Polyclonal Antibody to Fibulin 3 (FBLN3) | WB; IHC; ICC; IP. |
| PAF422Hu02 | Polyclonal Antibody to Fibulin 3 (FBLN3) | WB; IHC; ICC; IP. |
| LAF422Hu71 | Biotin-Linked Polyclonal Antibody to Fibulin 3 (FBLN3) | WB; IHC; ICC. |
| MAF422Hu22 | Monoclonal Antibody to Fibulin 3 (FBLN3) | WB |
| MAF422Hu25 | Monoclonal Antibody to Fibulin 3 (FBLN3) | WB |
| MAF422Hu21 | Monoclonal Antibody to Fibulin 3 (FBLN3) | WB |
| SEF422Hu | ELISA Kit for Fibulin 3 (FBLN3) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCF422Hu | CLIA Kit for Fibulin 3 (FBLN3) | Chemiluminescent immunoassay for Antigen Detection. |
| LMF422Hu | Magnetic Luminex Assay Kit for Fibulin 3 (FBLN3) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
